FDLSX
Price
$16.29
Change
+$0.10 (+0.62%)
Updated
Jun 23 closing price
Net Assets
476.83M
RYLAX
Price
$83.09
Change
+$0.39 (+0.47%)
Updated
Jun 23 closing price
Net Assets
6.1M
Interact to see
Advertisement

FDLSX vs RYLAX

FDLSX vs RYLAX Comparison Chart in %
View a ticker or compare two or three
VS
FDLSX vs. RYLAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDLSX is a Buy and RYLAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FDLSX has more cash in the bank: 477M vs. RYLAX (6.1M). FDLSX pays higher dividends than RYLAX: FDLSX (0.55) vs RYLAX (0.07). FDLSX was incepted earlier than RYLAX: FDLSX (42 years) vs RYLAX (28 years). RYLAX (1.68) is less costly to investors than FDLSX (0.68). RYLAX is a more actively managed with annual turnover of: 263.00 vs. FDLSX (65.00). FDLSX has a lower initial minimum investment than RYLAX: FDLSX (0) vs RYLAX (2500). RYLAX IRA initial investment is lower compared to FDLSX: RYLAX (1000) vs FDLSX (500). RYLAX annual gain was more profitable for investors over the last year : -4.13 vs. FDLSX (-19.60). RYLAX return over 5 years is better than : -9.76 vs. FDLSX (-13.43).
FDLSXRYLAXFDLSX / RYLAX
Total Expense Ratio0.681.6342%
Annual Report Gross Expense Ratio0.681.6840%
Fund Existence42 years28 years-
Gain YTD-8.818-5.073174%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRA500100050%
Net Assets477M6.1M7,818%
Annual Yield % from dividends0.550.07808%
Returns for 1 year-19.60-4.13474%
Returns for 3 years-0.9030.08-3%
Returns for 5 years-13.43-9.76138%
Returns for 10 years31.9059.0754%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMS1.470.05
+3.52%
American Shared Hospital Services
CRBP8.440.13
+1.62%
Corbus Pharmaceuticals Holdings
RNST42.750.64
+1.52%
Renasant Corp
ESPR3.16N/A
N/A
Esperion Therapeutics
KGC25.01-1.29
-4.90%
Kinross Gold Corp